生物来源
rabbit
质量水平
重组
expressed in HEK 293 cells
偶联物
unconjugated
抗体形式
purified antibody
抗体产品类型
primary antibodies
克隆
1N22, recombinant monoclonal
描述
recombinant, expressed in HEK 293 cells
产品线
ZooMAb® learn more
表单
lyophilized
分子量
calculated mol wt 63.36 kDa
observed mol wt ~60 kDa
纯化方式
using Protein A
种属反应性
human
包装
antibody small pack of 25
增强验证
recombinant expression
Learn more about Antibody Enhanced Validation
技术
ELISA: suitable
affinity binding assay: suitable
western blot: suitable
同位素/亚型
IgG
表位序列
N-terminal extracellular domain
Protein ID登记号
UniProt登记号
运输
ambient
储存温度
2-8°C
基因信息
human ... IL1RL1(9173)
一般描述
ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.
Interleukin-1 receptor-like 1 (UniProt: Q01638; also known as Protein ST2) is encoded by the IL1RL1 (also known as DER4, ST2, T1) gene (Gene ID: 9173) in human. Interleukin-33 receptor (IL-33R) is a member of the IL-1 receptor family and plays a pivotal role in immune regulation. IL-33R forms a signaling complex by binding IL-33 and recruiting the IL-1 receptor accessory protein (IL-1RAcP), which facilitates downstream signal transduction. This interaction engages MyD88, leading to activation of NF- B and MAPK pathways, crucial for inflammatory responses. The receptor′s expression is predominantly observed on Th2 cells, regulatory T cells (Tregs), group 2 innate lymphoid cells (ILC2s), mast cells, and other leukocytes, underscoring its role in type 2 immunity. IL-33R mediates the effects of IL-33, a cytokine involved in promoting Th2-associated cytokine production, such as IL-4, IL-5, and IL-13. This axis is essential for the development of allergic inflammation, asthma, and other chronic inflammatory diseases. Additionally, IL-33R signaling contributes to tissue repair, parasite defense, and neuroimmune regulation. Dysregulation of IL-33R signaling has been implicated in various pathologies, including autoimmune diseases, cardiovascular diseases, and cancer. This ZooMAb® recombinant monoclonal antibody, generated by our proprietary technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Jiménez-Munguía, I., et al., (2022), Curr. Opin. Struct. Biol., 77, 102467).
Interleukin-1 receptor-like 1 (UniProt: Q01638; also known as Protein ST2) is encoded by the IL1RL1 (also known as DER4, ST2, T1) gene (Gene ID: 9173) in human. Interleukin-33 receptor (IL-33R) is a member of the IL-1 receptor family and plays a pivotal role in immune regulation. IL-33R forms a signaling complex by binding IL-33 and recruiting the IL-1 receptor accessory protein (IL-1RAcP), which facilitates downstream signal transduction. This interaction engages MyD88, leading to activation of NF- B and MAPK pathways, crucial for inflammatory responses. The receptor′s expression is predominantly observed on Th2 cells, regulatory T cells (Tregs), group 2 innate lymphoid cells (ILC2s), mast cells, and other leukocytes, underscoring its role in type 2 immunity. IL-33R mediates the effects of IL-33, a cytokine involved in promoting Th2-associated cytokine production, such as IL-4, IL-5, and IL-13. This axis is essential for the development of allergic inflammation, asthma, and other chronic inflammatory diseases. Additionally, IL-33R signaling contributes to tissue repair, parasite defense, and neuroimmune regulation. Dysregulation of IL-33R signaling has been implicated in various pathologies, including autoimmune diseases, cardiovascular diseases, and cancer. This ZooMAb® recombinant monoclonal antibody, generated by our proprietary technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Jiménez-Munguía, I., et al., (2022), Curr. Opin. Struct. Biol., 77, 102467).
免疫原
KLH-conjugated linear peptide corresponding to 25 amino acids from the N-terminal extracellular domain of human ST2/IL-33R.
应用
Quality Control Testing
Evaluated by Western Blotting using a His-tagged, recombinant fragment of human ST2/IL-33R protein.
Western Blotting Analysis: 1:10,000 of this antibody detected a His-tagged, recombinant fragment of human ST2/IL-33R protein.
Tested Applications
Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected ST2/IL-33R in human kidney tissue lysate.
Affinity Binding Assay: A representative lot of this antibody bound with ST2/IL-33R peptide with at least one billion-fold (1,000,000,000X) higher affinity than with non-specific control peptide.
Enzyme Immunoassay: A variety dilutions of representative lot of this antibody detected ST2/IL-33R protein in ELISA application.
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Evaluated by Western Blotting using a His-tagged, recombinant fragment of human ST2/IL-33R protein.
Western Blotting Analysis: 1:10,000 of this antibody detected a His-tagged, recombinant fragment of human ST2/IL-33R protein.
Tested Applications
Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected ST2/IL-33R in human kidney tissue lysate.
Affinity Binding Assay: A representative lot of this antibody bound with ST2/IL-33R peptide with at least one billion-fold (1,000,000,000X) higher affinity than with non-specific control peptide.
Enzyme Immunoassay: A variety dilutions of representative lot of this antibody detected ST2/IL-33R protein in ELISA application.
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
生化/生理作用
Clone 1N22 is a ZooMAb® rabbit recombinant monoclonal antibody that detects ST2/IL-33R. It targets an epitope within 25 amino acids from the N-terminal extracellular domain.
外形
Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.
制备说明
300 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
法律信息
ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
免责声明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
